EUVIMEDEUVIMED entdecken
Multizentrische StudieKohortenstudieOpen Access

Changing Patterns of Diagnosis and Survival in Transthyretin Cardiac Amyloidosis: A Multicenter Cohort Study

Brett W Sperry iD, Ahmad Masri iD, Prem Soman iD, Ain U Ejaz, Priyanka Bhattacharya iD, Brent Medoff iD, Pranav Chandrashekar iD, Lauren Ives iD, Alfonsina Mirabal Santos iD, Sergio L Teruya iD, Yanjun Wu iD, Yuanzi Zhao und 3 weitere

Journal of the American Heart Association · 2025

DOI: 10.1161/jaha.125.042530 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of the American Heart Association, 2025. Verfasst von Brett W Sperry und 14 weiteren Autor:innen. Beteiligte Einrichtung: Saint Luke's Mid America Heart Institute Kansas City MO USA. Hauptthemen laut MEDLINE: Amyloid Neuropathies, Familial, Cardiomyopathies. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Diagnostic rates of transthyretin cardiac amyloidosis have increased due to growing awareness, noninvasive diagnoses, and treatments that improve morbidity and mortality. We sought to investigate real‐world trends in baseline characteristics and survival in the United States.

Methods

Patient‐level data at 5 cardiac amyloid referral centers were used, and mortality (defined as death or surgical heart failure therapies) was compared by eras (pre‐2010, 2010–2013, 2014–2017, and 2018–2021) and National Amyloidosis Center (NAC) stage.

Results

Among 1165 subjects, diagnosis of transthyretin cardiac amyloidosis in a more recent era was associated with older age, white race, wild‐type disease, and tafamidis treatment ( P 1 portended an increased risk of death (stage 2: HR, 2.00; P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyloid Neuropathies, FamilialCardiomyopathiesHumansMaleFemaleAgedUnited StatesMiddle AgedBenzoxazolesAged, 80 and overRetrospective StudiesSurvival RateRisk Factors

Stichwörter der Autor:innen

ATTRcardiomyopathyheart failurelight chain

Substanzen

Benzoxazolestafamidis

Autor:innen und Institutionen

  • Saint Luke's Mid America Heart Institute Kansas City MO USA.
  • Oregon Health Sciences University Portland OR USA.
  • University of Pittsburgh Medical Center Pittsburgh PA USA.
  • Columbia University Irving Medical Center New York NY USA.
  • Cleveland Clinic Foundation Cleveland OH USA.

ORCID-Profile: Brett W Sperry, Ahmad Masri, Prem Soman, Priyanka Bhattacharya, Brent Medoff, Pranav Chandrashekar, Lauren Ives, Alfonsina Mirabal Santos, Sergio L Teruya, Yanjun Wu, Xiaofeng Wang, Mathew S Maurer

Förderung

  • NIA NIH HHS
  • NHLBI NIH HHS

Zitieren

APA

Sperry, B. W., Masri, A., Soman, P., Ejaz, A. U., Bhattacharya, P., Medoff, B., Chandrashekar, P., Ives, L., Mirabal Santos, A., Teruya, S. L., Wu, Y., Zhao, Y., Wang, X., Maurer, M. S., & Hanna, M. (2025). Changing Patterns of Diagnosis and Survival in Transthyretin Cardiac Amyloidosis: A Multicenter Cohort Study. Journal of the American Heart Association. https://doi.org/10.1161/jaha.125.042530

Vancouver

Sperry BW, Masri A, Soman P, Ejaz AU, Bhattacharya P, Medoff B, et al. Changing Patterns of Diagnosis and Survival in Transthyretin Cardiac Amyloidosis: A Multicenter Cohort Study. Journal of the American Heart Association. 2025. doi:10.1161/jaha.125.042530

BibTeX
@article{Sperry2025,
  author = {Sperry, Brett W and Masri, Ahmad and Soman, Prem and Ejaz, Ain U and Bhattacharya, Priyanka and Medoff, Brent and Chandrashekar, Pranav and Ives, Lauren and Mirabal Santos, Alfonsina and Teruya, Sergio L and Wu, Yanjun and Zhao, Yuanzi and Wang, Xiaofeng and Maurer, Mathew S and Hanna, Mazen},
  title = {Changing Patterns of Diagnosis and Survival in Transthyretin Cardiac Amyloidosis: A Multicenter Cohort Study},
  journal = {Journal of the American Heart Association},
  year = {2025},
  doi = {10.1161/jaha.125.042530}
}
Kostenlos starten →